Xiao-yan He

Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis.

Xiao-ming Meng, Q. Gong, Hao Lu, 2022, European journal of pharmacology.

Highly pathogenic coronaviruses and the kidney

Xiao-ming Meng, W. Ni, Juan Jin, 2022, Biomedicine & Pharmacotherapy.

RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.

Xiao-ming Meng, Zeng Li, W. Ni, 2022, International immunopharmacology.

Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms

Fang Wang, Xiao-ming Meng, Hai-yong Chen, 2022, Science Translational Medicine.

Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS production

Taotao Ma, Xiao-ming Meng, Jun Li, 2020, Redox biology.

Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis

Xiao-ming Meng, Jun Li, Yu Cai, 2021, Acta Pharmacologica Sinica.

Inflammatory phenotypes in stable and acute childhood asthma.

J. Simpson, F. Wang, Xiao-yan He, 2011, Paediatric respiratory reviews.

Compound‐42 alleviates acute kidney injury by targeting RIPK3‐mediated necroptosis

Ying Chen, Ming Liu, Fang Wang, 2023, British journal of pharmacology.